Severe acute respiratory syndrome coronavirus 2 immunity: infective and naive incidence in fertility clinics after lockdown - 30/06/21
Doi : 10.1016/j.ajog.2021.03.008
Le texte complet de cet article est disponible en PDF.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
Plan
| R.F. and D.S. contributed equally to this work. |
|
| R.K., D.V., and J.C. are employed by Igenomix USA LLC, and C.S. is the Head of the Scientific Advisory Board of Igenomix. R.F. and D.S. are employees in the different fertility centers that participated in this study. |
|
| This study has been funded by Igenomix USA LLC, which is the promoter of the study. |
|
| The findings in this paper were presented as poster at the “Virtual Congress ASRM 2020,” October 21, 2020. |
|
| ClinicalTrials.gov (ID NCT 04466644); www.clinicaltrials.gov. |
© 2021
Elsevier Inc. Tous droits réservés.
Vol 225 - N° 1
P. 103-105 - juillet 2021 Retour au numéro
Article précédent
- Anti–severe acute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer-BioNTech/BNT162b2 vaccination
- Jeannie C. Kelly, Ebony B. Carter, Nandini Raghuraman, Lila S. Nolan, Qingqing Gong, Angela N. Lewis, Misty Good
- Fetal heart rate pattern in term or near-term cerebral palsy: looking at the data in the right perspective
- Salvatore Politi, Edwin Chandraharan, Tullio Ghi
Bienvenue sur EM-consulte, la référence des professionnels de santé.